【摘要】 目的探讨首发急性心肌梗死(AMI)患者血浆可溶性血栓调节蛋白(soluble thrombomodulin,sTM)水平对近期预后的影响。方法将74例首发AMI患者分为有心血管事件组21例,无心血管事件组53例。应用酶联免疫吸附法(ELISA)检测2组sTM的血浆浓度。结果有心血管事件组sTM水平(7.27±1.76)ng/L;无心血管事件组sTM水平(4.48±0.97)ng/L,2组比较差异有统计学意义(P<0.05)。结论AMI患者可溶性血栓调节蛋白水平对近期预后有良好的评价作用。更多还原

【Abstract】 Objective: To investigate the first patients with acute myocardial infarction Soluble thrombomodulin(sTM) in the evaluation of short-term prognosis.Methods 74 cases of first-episode AMI will be different 2 Groups,there cardiovascular events be 21 cases,no cardiovascular events be 53 cases.enzyme-linked immunosorbent assay(ELISA) for measurement of plasma concentrations of sTM.Results There cardiovascular events sTM level(7.27±1.76)ng/L;no cardiovascular events sTM levels(4.48±0.97)ng/L,respectively,the difference was significant(P<0.05).Conclusion The first patients with acute myocardial infarction Soluble thrombomodulin levels will be on the short-term prognosis good evaluation role.更多还原